Function and mechanism of LGR4 and LGR5 in Modulation of Wnt Signaling
LGR4和LGR5在Wnt信号传导调节中的功能和机制
基本信息
- 批准号:10000924
- 负责人:
- 金额:$ 30.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AblationActinsAffinityArchitectureArrestinsBindingBiologyCancer cell lineCell AdhesionCell LineCell SurvivalCell physiologyCell-Cell AdhesionCellsCessation of lifeChemosensitizationColon CarcinomaComplementComplexCytoskeletonDefectDevelopmentDiseaseEmbryoEnzymesEpithelialEpitheliumExtracellular DomainFamilyFoundationsFundingG-Protein-Coupled ReceptorsGPR4 geneGastrointestinal tract structureGene FusionGenesGoalsGrowth FactorHeterotrimeric GTP-Binding ProteinsHumanIQ motif containing GTPase activating protein 1In VitroIntestinesKnock-outKnowledgeLGR5 geneLRRC17 geneLaboratoriesLeucine-Rich RepeatLigandsMaintenanceMalignant NeoplasmsMalignant neoplasm of prostateMediatingMediator of activation proteinMitogen-Activated Protein KinasesMolecularMusMutationNormal tissue morphologyOrganOrgan SurvivalOrganoidsPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhysiologicalPlayProtein DephosphorylationProteinsReceptor SignalingRecurrenceRegenerative MedicineRegulationReportingResearchRhodopsinRoleScaffolding ProteinSignal TransductionStem Cell FactorStructureSystemTestingTissuesTransducersTranslatingWNT Signaling PathwayWorkadult stem cellbench to bedsidebeta catenincancer cellcancer therapycell motilitydesignfitnesshuman diseasein vivoinsightintestinal cryptknock-downnew therapeutic targetnovel therapeuticsnull mutationorgan growthoverexpressionpublic health relevancereceptorreceptor bindingrecruitrepairedself-renewalsimulationstem cellstherapeutic developmenttumorigenesisubiquitin ligaseubiquitin-protein ligase
项目摘要
Project title: Function and mechanism of LGR4 and LGR5 in modulation of Wnt signaling
Abstract
LGR4 and LGR5 (leucine-rich repeat containing G protein-coupled receptor 4 and 5) are two
related receptors of the rhodopsin-like 7TM receptor superfamily with critical roles in
development and oncogenesis. Heterozygous mutation of LGR4 is associated with several
human diseases while complete knockout of LGR4 in mice leads to embryonic lethality with
hypoplasia and defective tubulogenesis in several organs. LGR5 is now the most recognized
marker of adult stem cells in the gastrointestinal tract and other epithelial tissues, although it is
not essential for the self-renewal of LGR5-positive stem cells. We and others discovered that
LGR4/5 function as receptors of R-spondins (RSPOs) to potentiate Wnt signaling. RSPOs are a
group of four related secreted proteins (RSPO1-4) with distinct roles in organ development and
survival of stem cells. Recently, recurrent gene fusions of RSPO2 and RSPO3 were identified
in a subset of colon and prostate cancers. The discovery of RSPOs as ligand of LGR4/5
provides a molecular basis for stem cell-specific effect of the Wnt signaling and for the
pleiotropic functions that LGR4/5 and R-spondins have in development, stem cell survival, and
oncogenesis. Despite containing a 7TM domain typical of the rhodopsin family of GPCRs,
simulation of LGR4/5 by RSPOs does not lead to activation of heterotrimeric G proteins or -
arrestin. Instead, RSPO-LGR4 potentiates Wnt signaling via two pathways, inhibition of
ubiquitin ligases that degrade Wnt receptors and recruitment of the scaffold protein IQGAP1 that
coordinate Wnt signaling. However, the exact roles and signaling mechanisms of the RSPO-
LGR4/5 system in the regulation of stem cell fitness and Wnt signaling remain poorly
understood. In this proposal, we will carry out three aims to dissect how RSPO, LGR4/5, and
IQGAP1 interact to regulate their downstream mediators, to identify and characterize the
function and mechanism of LGR5 in the regulation of cell-cell adhesion and stem cell fitness,
and to delineate the mechanisms of RSPO-LGR4 activation in potentiation of Wnt signaling.
The results and conclusions will provide important insights not only into the governing principles
of Wnt signaling and stem cell survival but also the discovery and development of novel
therapeutics in regenerative medicine and cancer treatment.
项目名称:LGR4和LGR5在Wnt信号调制中的作用和机制
摘要
LGR4和LGR5(富含亮氨酸重复序列,包含G蛋白偶联受体4和5)是两个
视紫红质样7TM受体超家族相关受体在细胞周期调控中的作用
发育和肿瘤发生。LGR4杂合突变与几个
人类疾病,而在小鼠中完全敲除LGR4会导致胚胎死亡
几个器官的发育不全和小管生成缺陷。LG5现在是最受认可的
胃肠道和其他上皮组织中的成体干细胞的标记,尽管它是
对LGR5阳性干细胞的自我更新不是必需的。我们和其他人发现
LGR4/5作为R-Spin(RSPO)的受体,增强Wnt信号转导。RSPO是一个
四组相关的分泌蛋白(Rspo1-4),在器官发育和
干细胞的存活。最近,rspO2和rsp3的复发基因融合被鉴定出来。
在结肠癌和前列腺癌的子集中。作为LGR4/5配体的RSPO的发现
为Wnt信号转导的干细胞特异性效应提供了分子基础
LGR4/5和R-Spinins在发育、干细胞存活和
致癌作用。尽管含有典型的GPCR视紫红质家族的7TM结构域,
RSPOS对LGR4/5的模拟不会导致异源三聚体G蛋白或-
阿瑞斯汀。相反,RSPO-LGR4通过两条途径增强Wnt信号,抑制
降解Wnt受体的泛素连接酶和支架蛋白IQGAP1的募集
协调WNT信令。然而,RSPO的确切作用和信号机制-
LGR4/5系统在调节干细胞适合性和Wnt信号中的作用仍然很差
明白了。在这项提案中,我们将实现三个目标,以剖析RSPO、LGR4/5和
IQGAP1相互作用以调节其下游介体,以识别和表征
LGR5在调节细胞间黏附和干细胞适合性中的作用和机制
并探讨RSPO-LGR4激活在Wnt信号增强中的作用机制。
结果和结论不仅将为指导原则提供重要的见解
研究Wnt信号与干细胞存活的同时也发现和发展了新的
再生医学和癌症治疗的治疗学。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis of LGR4 receptor distribution in human and mouse tissues.
- DOI:10.1371/journal.pone.0078144
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Yi J;Xiong W;Gong X;Bellister S;Ellis LM;Liu Q
- 通讯作者:Liu Q
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qingyun Liu其他文献
Qingyun Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qingyun Liu', 18)}}的其他基金
LGR5 antibody drug conjugate for the treatment of neuroblastoma
LGR5抗体药物缀合物用于治疗神经母细胞瘤
- 批准号:
10356494 - 财政年份:2021
- 资助金额:
$ 30.03万 - 项目类别:
LGR5 antibody drug conjugate for the treatment of neuroblastoma
LGR5抗体药物缀合物用于治疗神经母细胞瘤
- 批准号:
10532233 - 财政年份:2021
- 资助金额:
$ 30.03万 - 项目类别:
Function and mechanism of LGR4 and LGR5 in modulation of Wnt signaling
LGR4和LGR5在Wnt信号传导中的功能和机制
- 批准号:
8519480 - 财政年份:2012
- 资助金额:
$ 30.03万 - 项目类别:
Function and mechanism of LGR4 and LGR5 in modulation of Wnt signaling
LGR4和LGR5在Wnt信号传导中的功能和机制
- 批准号:
8645655 - 财政年份:2012
- 资助金额:
$ 30.03万 - 项目类别:
Function and mechanism of LGR4 and LGR5 in Modulation of Wnt Signaling
LGR4和LGR5在Wnt信号传导调节中的功能和机制
- 批准号:
9762122 - 财政年份:2012
- 资助金额:
$ 30.03万 - 项目类别:
Function and mechanism of LGR4 and LGR5 in modulation of Wnt signaling
LGR4和LGR5在Wnt信号传导中的功能和机制
- 批准号:
8350258 - 财政年份:2012
- 资助金额:
$ 30.03万 - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 30.03万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
$ 30.03万 - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
$ 30.03万 - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
$ 30.03万 - 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
- 批准号:
7931495 - 财政年份:2009
- 资助金额:
$ 30.03万 - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
$ 30.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
$ 30.03万 - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 30.03万 - 项目类别:














{{item.name}}会员




